SavedAdd your journal

Journals / Abant Tıp Dergisi / 2015 / Cilt: 4 - Sayı: 3

The Utility of the Serum Albumin Levels on Admission for Predicting Angiographic No Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

ST-Segment Yükselmesi Miyokard İnfarktüsülü Hastalarda Primer Perkütan Koroner Girişim Sonrası Anjiyografik Akışsızlık Fenomenini Öngürmede Başvuru Serum Albümin Düzeylerinin Yararı

Mehmet Ata AKIL
Mehmet Zihni BİLİK
Halit ACET
Mehmet ÖZBEK
Necdet OZAYDOĞDU
Leyla ÇİFTÇİ
Abdulkadir Yıldız YILDIZ
Hasan KAYA
Murat YÜKSEL
Nihat POLAT
Faruk ERTAŞ
Mesut AYDIN
Pages
230–238
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We defined angiographic no-reflow phenomenon as a coronary TIMI flow grade ≤2 after vessel re-canalized or TIMI flow grade 3 together with a final MBG

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Low serum albumin SA levels are associated with increased cardiovascular mortality.
📊
Key Findings & Data:We investigated whether baseline SA levels are associated with no-reflow in patients undergoing primary percutaneous coronary intervention p-PCI .
💡
Conclusion & Impact:We defined angiographic no-reflow phenomenon as a coronary TIMI flow grade ≤2 after vessel re-canalized or TIMI flow grade 3 together with a final MBG
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Serum albumin düzeyi · Akışsızlık fenomeni · Perkütan koroner girişim

Abstract

OBJECTIVE: Low serum albumin SA levels are associated with increased cardiovascular mortality. We investigated whether baseline SA levels are associated with no-reflow in patients undergoing primary percutaneous coronary intervention p-PCI . METHODS: STEMI patients treated by p-PCI were included in the study. The patients were followed during in hospital period. We defined angiographic no-reflow phenomenon as a coronary TIMI flow grade ≤2 after vessel re-canalized or TIMI flow grade 3 together with a final MBG

Özet

AMAÇ: Düşük serum albümin SA düzeyleri artmış kardiyovasküler mortalite ile ilişkilidir. Bazal SA seviyelerinin primer perkütan koroner girişim p-PKG yapılan hastalarda akışsızlık fenomeni ile ilgili olup olmadığını araştırdık.YÖNTEMLER: Geriye dönük olarak p-PKG ile tedavi edilen ST yükselmeli myokard infarktüsü STYMI ’lı 358 hasta alındı. Hasta takibi hastaneiçi dönemde yapıldı. Önceki çalışmalara uygun olarak, TIMI akım derecesi ≤2, TIMI akım derecesi >3 olanlarda ise MBG

🔖

Cite This Article

AKIL, M. A., BİLİK, M. Z., ACET, H., ÖZBEK, M., OZAYDOĞDU, N., ÇİFTÇİ, L., YILDIZ, A. Y., KAYA, H., YÜKSEL, M., POLAT, N., ERTAŞ, F., AYDIN, M. (2022). The Utility of the Serum Albumin Levels on Admission for Predicting Angiographic No Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Abant Tıp Dergisi, Cilt: 4 - Sayı: 3, 230–238. https://ajindex.com/articles/427081

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. the primary angioplasty in myocardial infarction study group. N Engl J Med. 1993;328(10):673-679
  2. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse longterm outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36(4):1202-1209
  3. Lee CH, Tse HF. Microvascular obstruction after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75(3): 369-377
  4. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008;72(7):950-957
  5. Peters T Jr. Serum albumin. Adv Protein Chem. 1985;37:161-245
  6. Nelson JJ, Liao D, Sharrett A, Folsom AR, Chambless LE, Shahar E, et al. Serum albumin level as a predictor of incident coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2000; 151:468–477
  7. Gresele P, Deckmyn H, Huybrechts E, Vermylen J. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol. 1984;33(13):2083-2088
  8. Mikhailidis DP, Barradas MA, Maris A, Jeremy JY, Dandona P. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol. 1985;38(10):1166-1171
  9. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 1997;52(3):761-770
  10. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2(8677):1434-1436
  11. Oduncu V, Erkol A, Karabay CY, et al. The prognostic value of serum albumin levels on admission in patients with acute STsegment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis. 2013; 24(2):88-94
  12. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13
  13. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary car